Veru Inc (VERU) Stock Analysis

Veru Inc (VERU) is a publicly traded company in the HEALTHCARE sector. It trades at $2.35, carries a market capitalization of $38.20M. This page summarizes the public market data, fundamentals, and frequently asked questions for VERU, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.35
• Market Cap: $38.20M
• EPS: $-0.80
• 52-Week High: $7.40
• 52-Week Low: $2.05

Market Sentiment

Veru Inc currently has a Bullish sentiment score of 0.29.

About Veru Inc

Veru Inc. is a clinical-stage biopharmaceutical company headquartered in Miami, Florida, specializing in the development of innovative therapeutics for oncology and other unmet medical needs. The company's pipeline includes a range of drug candidates aimed at addressing various types of cancers, with a particular emphasis on both novel treatments and enhancements to existing therapies. Committed to advancing patient care, Veru leverages its proprietary technology and scientific expertise to b...

GNG Research Analysis

GNG Research scores Veru Inc (VERU) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for VERU.

Frequently Asked Questions

Does VERU pay dividends?

Veru Inc (VERU) does not currently pay a regular dividend.

What is VERU's market cap?

Veru Inc (VERU) has a market capitalization of $38.20M with a current stock price of $2.35.